Skip to main content

Biodesix Inc

BDSX
Exchange
Nasdaq
Industry
Services-Medical Laboratories
SEC CIK
0001439725

In the last 90 days, Biodesix Inc insiders filed 2 open-market purchases and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $98.5M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Biodesix Inc changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of BDSX: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders4742−5
Shares5.12M4.24M−876.9K (−17.1%)
Value$67.6M$34.9M−$32.7M (−48.4%)

New holders (6)

Institutions that held Biodesix Inc at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to BDSX in Q3 2021
InstitutionSharesValue% of portfolio
Two Sigma Investments, LP38,991$321.0K0.00%
PDT Partners, LLC23,371$192.0K0.01%
Two Sigma Advisers, LP19,000$156.0K0.00%
Column Capital Advisors, LLC2,850$23.0K0.00%
Captrust Financial Advisors109$1.00K0.00%
Ellevest, Inc.12$00.00%

Sold out (11)

Institutions that held Biodesix Inc at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of BDSX in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Kornitzer Capital Management Inc437,530$5.78M
Asymmetry Capital Management, L.P.381,378$5.04M
RTW Investments, LP125,000$1.65M
Alyeska Investment Group, L.P.100,000$1.32M
Essex Investment Management Co LLC99,235$1.31M
Squarepoint Ops LLC35,000$462.0K
Atom Investors LP33,794$446.0K
Driehaus Capital Management LLC25,000$330.0K
Goldman Sachs Group Inc15,547$205.0K
ExodusPoint Capital Management, LP15,100$199.0K
Advisory Services Network, LLC39$1.00K